Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $380.99, for a total transaction of $380,990.00. Following the completion of the transaction, the director now directly owns 27,259 shares in the company, valued at approximately $10,385,406.41. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Axon Enterprise Trading Up 0.1 %
NASDAQ AXON opened at $383.01 on Thursday. The company has a current ratio of 2.88, a quick ratio of 2.52 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a 1-year low of $189.12 and a 1-year high of $387.61. The firm’s fifty day simple moving average is $342.26 and its 200-day simple moving average is $315.72. The company has a market capitalization of $28.94 billion, a PE ratio of 111.99, a price-to-earnings-growth ratio of 10.34 and a beta of 0.94.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The company had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s quarterly revenue was up 34.5% on a year-over-year basis. During the same period last year, the business earned $0.80 EPS. As a group, sell-side analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current fiscal year.
Institutional Trading of Axon Enterprise
Analyst Ratings Changes
AXON has been the subject of a number of research reports. Northland Securities raised their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Barclays raised their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th. Robert W. Baird upped their target price on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a research note on Wednesday, August 7th. Finally, Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $365.38.
Check Out Our Latest Stock Analysis on AXON
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- How Much Can You Make in Stocks in One Month?
- Trading Stocks: RSI and Why it’s Useful
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Plot Fibonacci Price Inflection Levels
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.